SE9803240D0
(sv)
|
1998-09-24 |
1998-09-24 |
Diabact Ab |
A pharmaceutical composition having a rapid action
|
EP1005863A1
(en)
*
|
1998-12-04 |
2000-06-07 |
Synthelabo |
Controlled-release dosage forms comprising a short acting hypnotic or a salt thereof
|
US20040258750A1
(en)
*
|
1999-06-28 |
2004-12-23 |
Gerard Alaux |
Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
MXPA02004293A
(es)
|
1999-10-29 |
2002-10-31 |
Euro Celtique Sa |
Formulaciones de hidrocodona de liberacion controlada..
|
AU5066101A
(en)
*
|
2000-04-13 |
2001-10-30 |
Synthon B.V. |
Modified release formulations containing a hypnotic agent
|
EP1337244A4
(en)
|
2000-10-30 |
2006-01-11 |
Euro Celtique Sa |
HYDROCODON FORMULATIONS WITH CONTROLLED RELEASE
|
US20030070584A1
(en)
|
2001-05-15 |
2003-04-17 |
Cynthia Gulian |
Dip coating compositions containing cellulose ethers
|
US7458374B2
(en)
|
2002-05-13 |
2008-12-02 |
Alexza Pharmaceuticals, Inc. |
Method and apparatus for vaporizing a compound
|
US7645442B2
(en)
|
2001-05-24 |
2010-01-12 |
Alexza Pharmaceuticals, Inc. |
Rapid-heating drug delivery article and method of use
|
US7766013B2
(en)
|
2001-06-05 |
2010-08-03 |
Alexza Pharmaceuticals, Inc. |
Aerosol generating method and device
|
DE60219478T2
(de)
*
|
2001-07-06 |
2008-01-03 |
Endo Pharmaceuticals Inc. |
Orale gabe von 6-hydroxy-oxymorphon als analgetikum
|
ATE376832T1
(de)
*
|
2001-07-06 |
2007-11-15 |
Penwest Pharmaceuticals Co |
Verzögert freisetzende formulierungen von oxymorphon
|
US8329216B2
(en)
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
US7332182B2
(en)
|
2001-08-06 |
2008-02-19 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and irritant
|
US7842307B2
(en)
|
2001-08-06 |
2010-11-30 |
Purdue Pharma L.P. |
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
|
US20030068276A1
(en)
|
2001-09-17 |
2003-04-10 |
Lyn Hughes |
Dosage forms
|
FR2829933B3
(fr)
*
|
2001-09-21 |
2004-03-12 |
Ellipse Pharmaceuticals |
Procede de fabrication d'un produit pharmaceutique administrable par voie orale avec des agents detrompeurs notamment de gout et produit obtenu
|
US8309118B2
(en)
|
2001-09-28 |
2012-11-13 |
Mcneil-Ppc, Inc. |
Film forming compositions containing sucralose
|
US8101209B2
(en)
|
2001-10-09 |
2012-01-24 |
Flamel Technologies |
Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
|
CN100553625C
(zh)
|
2002-04-09 |
2009-10-28 |
弗拉梅技术公司 |
活性成分微囊的口服混悬液
|
ATE407674T1
(de)
|
2002-04-09 |
2008-09-15 |
Flamel Tech Sa |
Orale pharmazeutische formulierung in form einer wässrigen suspension von mikrokapseln zur modifizierten freisetzung von amoxicillin
|
DE10250083A1
(de)
*
|
2002-06-17 |
2003-12-24 |
Gruenenthal Gmbh |
Gegen Missbrauch gesicherte Darreichungsform
|
US7776314B2
(en)
|
2002-06-17 |
2010-08-17 |
Grunenthal Gmbh |
Abuse-proofed dosage system
|
US8840928B2
(en)
|
2002-07-05 |
2014-09-23 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US8557291B2
(en)
|
2002-07-05 |
2013-10-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opioids and other drugs
|
US10004729B2
(en)
|
2002-07-05 |
2018-06-26 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
US7399488B2
(en)
*
|
2002-07-05 |
2008-07-15 |
Collegium Pharmaceutical, Inc. |
Abuse-deterrent pharmaceutical compositions of opiods and other drugs
|
EP1551402A4
(en)
|
2002-09-23 |
2009-05-27 |
Verion Inc |
PHARMACEUTICAL COMPOSITIONS NOT INDUCING ABUSE
|
DE10250084A1
(de)
*
|
2002-10-25 |
2004-05-06 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US7913688B2
(en)
|
2002-11-27 |
2011-03-29 |
Alexza Pharmaceuticals, Inc. |
Inhalation device for producing a drug aerosol
|
DE60309565T3
(de)
*
|
2003-05-02 |
2015-01-15 |
Dexcel Ltd. |
Tablettenzubereitung mit verlängerter Freisetzung von Venlafaxin
|
EP1622593A1
(en)
*
|
2003-05-02 |
2006-02-08 |
Warner-Lambert Company LLC |
Confectionery products for delivery of pharmaceutically active agents to the throat
|
DE102004020220A1
(de)
*
|
2004-04-22 |
2005-11-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
US8075872B2
(en)
|
2003-08-06 |
2011-12-13 |
Gruenenthal Gmbh |
Abuse-proofed dosage form
|
DE10361596A1
(de)
*
|
2003-12-24 |
2005-09-29 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
DE102004032051A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
|
DE10336400A1
(de)
*
|
2003-08-06 |
2005-03-24 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte Darreichungsform
|
US20070048228A1
(en)
|
2003-08-06 |
2007-03-01 |
Elisabeth Arkenau-Maric |
Abuse-proofed dosage form
|
DE102005005446A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Bruchfeste Darreichungsformen mit retardierter Freisetzung
|
US7201920B2
(en)
|
2003-11-26 |
2007-04-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of opioid containing dosage forms
|
AU2004305518A1
(en)
*
|
2003-12-15 |
2005-07-07 |
Alexza Pharmaceuticals, Inc. |
Treatment of breakthrough pain by drug aerosol inhalation
|
US20050165038A1
(en)
†
|
2004-01-22 |
2005-07-28 |
Maxwell Gordon |
Analgetic dosage forms that are resistant to parenteral and inhalation dosing and have reduced side effects
|
KR20150038745A
(ko)
*
|
2004-02-17 |
2015-04-08 |
트랜스셉트 파마슈티칼스, 인코포레이티드 |
구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
|
PL1740156T3
(pl)
*
|
2004-04-22 |
2011-12-30 |
Gruenenthal Gmbh |
Sposób wytwarzania zabezpieczonej przed nadużyciem, stałej postaci aplikacyjnej
|
ES2439572T3
(es)
*
|
2004-05-21 |
2014-01-23 |
Accu-Break Technologies, Inc. |
Comprimidos farmacéuticos de liberación inmediata de mayor altura que anchura
|
US7838031B2
(en)
|
2004-05-21 |
2010-11-23 |
Lawrence Solomon |
Method of administering a partial dose using a segmented pharmaceutical tablet
|
US7622137B2
(en)
*
|
2004-05-21 |
2009-11-24 |
Accu-Break Technologies, Inc. |
Dosage forms contained within a capsule or sachet
|
US7713547B2
(en)
|
2004-05-21 |
2010-05-11 |
Accu-Break Pharmaceuticals, Inc. |
Method of administering a partial dose of a segmented pharmaceutical tablet
|
US7780985B2
(en)
*
|
2005-07-12 |
2010-08-24 |
Accu-Break Technologies, Inc. |
Tablets having a printed separation mark to guide breaking
|
US7329418B2
(en)
*
|
2004-05-21 |
2008-02-12 |
Accu Break Technologies, Inc. |
Pharmaceutical tablets having height greater than width
|
US7318935B2
(en)
*
|
2004-05-21 |
2008-01-15 |
Accu-Break Technologies, Inc. |
Pharmaceutical tablets with active and inactive segments
|
US8216610B2
(en)
*
|
2004-05-28 |
2012-07-10 |
Imaginot Pty Ltd. |
Oral paracetamol formulations
|
US20080287456A1
(en)
*
|
2004-05-28 |
2008-11-20 |
Imaginot Pty Ltd |
Oral Therapeutic Compound Delivery System
|
US7540286B2
(en)
|
2004-06-03 |
2009-06-02 |
Alexza Pharmaceuticals, Inc. |
Multiple dose condensation aerosol devices and methods of forming condensation aerosols
|
DK1765292T3
(da)
|
2004-06-12 |
2018-01-02 |
Collegium Pharmaceutical Inc |
Misbrugs-forebyggende lægemiddelformuleringer
|
ITMI20041317A1
(it)
*
|
2004-06-30 |
2004-09-30 |
Ibsa Inst Biochimique Sa |
Formulazioni farmaceutiche per la somministrazione sicura di farmaci utilizzati nel trattamento della tossicodipendenza e procedimento per il loro ottenimento
|
DE102004032049A1
(de)
|
2004-07-01 |
2006-01-19 |
Grünenthal GmbH |
Gegen Missbrauch gesicherte, orale Darreichungsform
|
KR20070043806A
(ko)
*
|
2004-07-29 |
2007-04-25 |
사노피-아벤티스 |
pH에 매우 의존적인 용해도를 가지는 활성 성분의 제어방출을 위한 약제학적 다층 정제
|
WO2006017787A2
(en)
*
|
2004-08-06 |
2006-02-16 |
Grain Processing Corporation |
Tablet coating composition
|
FR2878161B1
(fr)
*
|
2004-11-23 |
2008-10-31 |
Flamel Technologies Sa |
Forme medicamenteuse orale, solide et concue pour eviter le mesusage
|
US20080152595A1
(en)
*
|
2004-11-24 |
2008-06-26 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20070231268A1
(en)
*
|
2004-11-24 |
2007-10-04 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
FR2878158B1
(fr)
*
|
2004-11-24 |
2009-01-16 |
Flamel Technologies Sa |
Forme pharmaceutique orale, microparticulaire solide concue pour eviter le mesusage
|
US20060110327A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
US20060177380A1
(en)
*
|
2004-11-24 |
2006-08-10 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse of orally administered pharmaceutical products
|
DE102005005449A1
(de)
|
2005-02-04 |
2006-08-10 |
Grünenthal GmbH |
Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
|
FR2881652B1
(fr)
*
|
2005-02-08 |
2007-05-25 |
Flamel Technologies Sa |
Forme pharmaceutique orale microparticulaire anti-mesuage
|
GB0506982D0
(en)
*
|
2005-04-06 |
2005-05-11 |
Mw Encap Ltd |
Abuse resistant capsules
|
KR100714616B1
(ko)
*
|
2005-06-23 |
2007-05-07 |
삼성전기주식회사 |
지수 함수 발생기 및 이를 이용한 가변 이득 증폭기
|
WO2007087452A2
(en)
*
|
2006-01-27 |
2007-08-02 |
Theraquest Biosciences, Llc |
Abuse resistant and extended release formulations and method of use thereof
|
US8329744B2
(en)
*
|
2005-11-02 |
2012-12-11 |
Relmada Therapeutics, Inc. |
Methods of preventing the serotonin syndrome and compositions for use thereof
|
US20100210732A1
(en)
*
|
2005-11-02 |
2010-08-19 |
Najib Babul |
Methods of Preventing the Serotonin Syndrome and Compositions for Use Therefor
|
US9125833B2
(en)
*
|
2005-11-02 |
2015-09-08 |
Relmada Therapeutics, Inc. |
Multimodal abuse resistant and extended release opioid formulations
|
US8652529B2
(en)
|
2005-11-10 |
2014-02-18 |
Flamel Technologies |
Anti-misuse microparticulate oral pharmaceutical form
|
US8148393B2
(en)
*
|
2005-11-18 |
2012-04-03 |
Synthon Bv |
Zolpidem tablets
|
WO2007058660A1
(en)
*
|
2005-11-18 |
2007-05-24 |
Accu-Break Technologies, Inc. |
Segmented pharmaceutical dosage forms
|
JP2009517346A
(ja)
|
2005-11-28 |
2009-04-30 |
イメイジノット ピーティーワイ エルティーディー |
治療用化合物の経口送達系
|
US8691272B2
(en)
*
|
2005-12-30 |
2014-04-08 |
Intelgenx Corp. |
Multilayer tablet
|
US20070264346A1
(en)
*
|
2006-02-16 |
2007-11-15 |
Flamel Technologies |
Multimicroparticulate pharmaceutical forms for oral administration
|
US20070237815A1
(en)
*
|
2006-04-06 |
2007-10-11 |
Lawrence Solomon |
Dosage forms and methods comprising amlodipine and chlorthalidone
|
JP4720620B2
(ja)
*
|
2006-05-30 |
2011-07-13 |
コニカミノルタビジネステクノロジーズ株式会社 |
カール補正装置及びこれを備えた画像形成装置
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
EP2049089A4
(en)
*
|
2006-08-08 |
2012-07-04 |
Accu Break Technologies Inc |
PHARMACEUTICAL TABLET CONTAINING A PLURALITY OF ACTIVE SEGMENTS
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
WO2008033351A2
(en)
*
|
2006-09-11 |
2008-03-20 |
Theraquest Biosciences, Inc. |
Multimodal abuse resistant and extended release formulations
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
US8187636B2
(en)
*
|
2006-09-25 |
2012-05-29 |
Atlantic Pharmaceuticals, Inc. |
Dosage forms for tamper prone therapeutic agents
|
JP2010511627A
(ja)
*
|
2006-11-30 |
2010-04-15 |
エーシーシーユー−ブレイク テクノロジーズ,インク. |
分割可能な浸透性剤形及びその使用方法
|
US20080145425A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Pliva Research & Development Limited |
Pharmaceutical composition of zolpidem
|
DE102007011485A1
(de)
|
2007-03-07 |
2008-09-11 |
Grünenthal GmbH |
Darreichungsform mit erschwertem Missbrauch
|
US20080216828A1
(en)
|
2007-03-09 |
2008-09-11 |
Alexza Pharmaceuticals, Inc. |
Heating unit for use in a drug delivery device
|
US8273798B2
(en)
*
|
2007-06-04 |
2012-09-25 |
Shear Kershman Laboratories |
Tamper resistant lipid-based oral dosage form for opioid agonists
|
WO2008155620A1
(en)
*
|
2007-06-20 |
2008-12-24 |
Develco Pharma Schweiz Ag |
Dosage form containing dispersible matrix of sustained release granules
|
US20080318993A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Hepatic Impairment
|
US20080318994A1
(en)
*
|
2007-06-21 |
2008-12-25 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instruction on Dosing for Renal Impairment
|
US20090004231A1
(en)
|
2007-06-30 |
2009-01-01 |
Popp Shane M |
Pharmaceutical dosage forms fabricated with nanomaterials for quality monitoring
|
CA2696341C
(en)
|
2007-08-13 |
2016-05-17 |
Abuse Deterrent Pharmaceutical Llc |
Abuse resistant drugs, method of use and method of making
|
RU2010129907A
(ru)
|
2007-12-17 |
2012-01-27 |
Лабофарм Инк. (CA) |
Лекарственная форма с контролируемым высвобождением, предотвращающая неправильное употребление
|
WO2009092601A1
(en)
|
2008-01-25 |
2009-07-30 |
Grünenthal GmbH |
Pharmaceutical dosage form
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
MX2010012039A
(es)
|
2008-05-09 |
2010-11-30 |
Gruenenthal Gmbh |
Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
|
US8420700B1
(en)
*
|
2008-06-04 |
2013-04-16 |
James M. Bausch |
Tamper resistant lipid-based oral dosage form for sympathomimetic amines
|
PL2352494T3
(pl)
|
2008-10-30 |
2020-03-31 |
Grünenthal GmbH |
Nowe i silne postaci dawkowania tapentadolu
|
WO2010066034A1
(en)
*
|
2008-12-12 |
2010-06-17 |
Paladin Labs Inc. |
Methadone formulation
|
CA2746888C
(en)
*
|
2008-12-16 |
2015-05-12 |
Labopharm (Barbados) Limited |
Misuse preventative, controlled release formulation
|
AU2010208240A1
(en)
|
2009-01-30 |
2011-09-22 |
Sunovion Pharmaceuticals Inc |
Coated tablets of 6-(5-chloro-2-pyridyl) -5-[ (4-methyl-1-piperazinyl) carbonyloxy]-7-oxo-6, 7-dihydro-5H-pyrrol o [3,4-b] pyrazine and methods for measuring effectiveness of coating
|
BR112012001547A2
(pt)
|
2009-07-22 |
2016-03-08 |
Gruenenthal Gmbh |
forma de dosagem farmacêutica extrusada por fusão a quente
|
RU2567723C2
(ru)
|
2009-07-22 |
2015-11-10 |
Грюненталь Гмбх |
Стабильная при окислении, прочная на излом лекарственная форма
|
CA2775890C
(en)
*
|
2009-09-30 |
2016-06-21 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for deterring abuse
|
US10610528B2
(en)
|
2009-12-08 |
2020-04-07 |
Intelgenx Corp. |
Solid oral film dosage forms and methods for making same
|
US20110136815A1
(en)
|
2009-12-08 |
2011-06-09 |
Horst Zerbe |
Solid oral film dosage forms and methods for making same
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
ES2606227T3
(es)
|
2010-02-03 |
2017-03-23 |
Grünenthal GmbH |
Preparación de una composición farmacéutica en polvo mediante una extrusora
|
JP5819329B2
(ja)
*
|
2010-03-09 |
2015-11-24 |
アルカーメス ファーマ アイルランド リミテッド |
アルコール耐性腸溶性医薬組成物
|
US8927025B2
(en)
|
2010-05-11 |
2015-01-06 |
Cima Labs Inc. |
Alcohol-resistant metoprolol-containing extended-release oral dosage forms
|
PE20131126A1
(es)
|
2010-09-02 |
2013-10-21 |
Gruenenthal Chemie |
Forma de dosificacion resistente a alteracion que comprende un polimero anionico
|
RU2604676C2
(ru)
|
2010-09-02 |
2016-12-10 |
Грюненталь Гмбх |
Устойчивая к разрушению лекарственная форма, содержащая неорганическую соль
|
PL2826467T3
(pl)
|
2010-12-22 |
2018-01-31 |
Purdue Pharma Lp |
Zamknięte, zabezpieczone przed manipulowaniem formy dozowania o kontrolowanym uwalnianiu
|
ES2581323T3
(es)
|
2010-12-23 |
2016-09-05 |
Purdue Pharma Lp |
Formas de dosificación oral sólida resistentes a alteraciones
|
CA2837077A1
(en)
*
|
2011-06-01 |
2012-12-06 |
Fmc Corporation |
Controlled release solid dose forms
|
DK2736497T3
(da)
|
2011-07-29 |
2017-11-13 |
Gruenenthal Gmbh |
Stød-resistent tablet, der tilvejebringer en øjeblikkelig frigivelse af et lægemiddel.
|
CA2839123A1
(en)
|
2011-07-29 |
2013-02-07 |
Grunenthal Gmbh |
Tamper-resistant tablet providing immediate drug release
|
MX347961B
(es)
*
|
2011-09-16 |
2017-05-19 |
Purdue Pharma Lp |
Formulaciones de liberación inmediata resistentes a alteración.
|
FR2983409B1
(fr)
*
|
2011-12-06 |
2013-12-27 |
Ethypharm Sa |
Comprime susceptible de lutter contre le detournement par voie injectable
|
US20130225697A1
(en)
|
2012-02-28 |
2013-08-29 |
Grunenthal Gmbh |
Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
|
ES2699806T3
(es)
|
2012-04-18 |
2019-02-12 |
SpecGx LLC |
Composiciones farmacéuticas, disuasivas del abuso, de liberación inmediata
|
WO2013156453A1
(en)
|
2012-04-18 |
2013-10-24 |
Grünenthal GmbH |
Tamper resistant and dose-dumping resistant pharmaceutical dosage form
|
US10064945B2
(en)
|
2012-05-11 |
2018-09-04 |
Gruenenthal Gmbh |
Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
|
PL2872121T3
(pl)
|
2012-07-12 |
2019-02-28 |
SpecGx LLC |
Kompozycje farmaceutyczne o przedłużonym uwalnianiu, zniechęcające do nadużywania
|
MX366159B
(es)
|
2012-11-30 |
2019-07-01 |
Acura Pharmaceuticals Inc |
Liberacion autorregulada de ingrediente farmaceutico activo.
|
AP2015008579A0
(en)
|
2013-02-05 |
2015-07-31 |
Purdue Pharma Lp |
Tamper resistant pharmaceutical formulations
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
US20140275038A1
(en)
|
2013-03-15 |
2014-09-18 |
Inspirion Delivery Technologies, Llc |
Abuse deterrent compositions and methods of use
|
ES2681952T3
(es)
|
2013-03-15 |
2018-09-17 |
SpecGx LLC |
Forma farmacéutica sólida disuasoria del abuso de liberación inmediata con puntaje funcional
|
AR096438A1
(es)
|
2013-05-29 |
2015-12-30 |
Gruenenthal Gmbh |
Forma de dosificación resistente al uso indebido con perfil de liberación bimodal, proceso
|
CA2907950A1
(en)
|
2013-05-29 |
2014-12-04 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing one or more particles
|
AU2014289187B2
(en)
|
2013-07-12 |
2019-07-11 |
Grunenthal Gmbh |
Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
|
CA2923721A1
(en)
*
|
2013-09-09 |
2015-03-12 |
Nova Southeastern University |
Deterring abuse of pharmaceutical products and alcohol
|
WO2015054701A2
(en)
|
2013-10-13 |
2015-04-16 |
Nova Southeastern University |
Analyzing immune signaling networks for identification of therapeutic targets in complex chronic medical disorders, identification of a natural killer cell population as a potential therapeutic target for gulf war illness & myalgic encephalomyelitis/chronic fatigue syndrome, and modulation of natural killer cell function by stimulation with interleukin 15
|
WO2015065547A1
(en)
|
2013-10-31 |
2015-05-07 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
CA2900858C
(en)
*
|
2013-10-31 |
2017-05-02 |
Cima Labs Inc. |
Immediate release abuse-deterrent granulated dosage forms
|
MX371372B
(es)
|
2013-11-26 |
2020-01-28 |
Gruenenthal Gmbh |
Preparacion de una composicion farmaceutica en polvo por medio de criomolienda.
|
US10105360B2
(en)
|
2013-12-11 |
2018-10-23 |
Develco Pharma Schweiz Ag |
Method and composition for the treatment of opioid induced constipation
|
EP3079676A1
(en)
|
2013-12-11 |
2016-10-19 |
Sun Pharmaceutical Industries Ltd |
Crush-resistant solid oral dosage form
|
WO2015086528A1
(de)
|
2013-12-11 |
2015-06-18 |
Develco Pharma Schweiz Ag |
Naloxon-monopräparat und mehrschichttablette
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
AU2015237723B2
(en)
|
2014-03-26 |
2018-04-26 |
Sun Pharma Advanced Research Company Ltd. |
Abuse deterrent immediate release biphasic matrix solid dosage form
|
EP3142646A1
(en)
|
2014-05-12 |
2017-03-22 |
Grünenthal GmbH |
Tamper resistant immediate release capsule formulation comprising tapentadol
|
JP2017516789A
(ja)
|
2014-05-26 |
2017-06-22 |
グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング |
エタノール過量放出に対して防護されている多粒子
|
PT3164117T
(pt)
|
2014-07-03 |
2023-12-12 |
SpecGx LLC |
Formulações de libertação imediata de dissuasão de abuso compreendendo polissacáridos não celulósicos
|
CA2910865C
(en)
|
2014-07-15 |
2016-11-29 |
Isa Odidi |
Compositions and methods for reducing overdose
|
US9132096B1
(en)
|
2014-09-12 |
2015-09-15 |
Alkermes Pharma Ireland Limited |
Abuse resistant pharmaceutical compositions
|
US10729685B2
(en)
|
2014-09-15 |
2020-08-04 |
Ohemo Life Sciences Inc. |
Orally administrable compositions and methods of deterring abuse by intranasal administration
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
KR20170139158A
(ko)
|
2015-04-24 |
2017-12-18 |
그뤼넨탈 게엠베하 |
즉시 방출되고 용매 추출 방지된 변조 방지된 투여 형태
|
US11103581B2
(en)
|
2015-08-31 |
2021-08-31 |
Acura Pharmaceuticals, Inc. |
Methods and compositions for self-regulated release of active pharmaceutical ingredient
|
CA2998259A1
(en)
|
2015-09-10 |
2017-03-16 |
Grunenthal Gmbh |
Protecting oral overdose with abuse deterrent immediate release formulations
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
EP3856160A4
(en)
|
2018-09-25 |
2022-07-06 |
SpecGx LLC |
ANTI-ABUSE IMMEDIATE RELEASE CAPSULES DOSAGE FORMS
|
JP7304691B2
(ja)
*
|
2018-12-06 |
2023-07-07 |
日本ケミファ株式会社 |
ゾピクロン、その光学異性体又はこれらの塩の何れかを有効成分として含有する錠剤
|
GR1009791B
(el)
|
2019-03-26 |
2020-08-03 |
Φαρματεν Α.Β.Ε.Ε. |
Σκευασμα παρατεταμενης αποδεσμευσης που περιλαμβανει ταπενταδολη και μεθοδος παρασκευης αυτου
|
US20220062200A1
(en)
|
2019-05-07 |
2022-03-03 |
Clexio Biosciences Ltd. |
Abuse-deterrent dosage forms containing esketamine
|
EP3965733A4
(en)
|
2019-05-07 |
2023-01-11 |
Clexio Biosciences Ltd. |
ABUSE DETERRENT DOSAGE FORMS CONTAINING ESKETAMINE
|